zur Startseite WORST CASE. Das Buch.
zur Startseite
zur Startseite



Interview: vfa Pharmabranche im Gespräch mit LifeGen.de

Währungsreform: Bundesbank-Präsident beantwortet keine Fragen

BP Ölpest: Alle News

Vulkanausbruch Island: Alle News zur Aschewolke - laufend aktualisiert. Volcanic Ash Cloud News

Swine Flu H1N1: Alle News zur Schweinegrippe - laufend aktualisiert

Bundesrepublik stellt sich auf massiven Anstieg der Inflation ein

H5N1 out of control: Labs under bioterrorist and pandemic threat

SPECIAL REPORT: Barack Obama under nuclear threat

Energiekrise: Wasserstoff macht Benzin und Diesel überflüssig

Klimawandel: Norddeutschland droht auf 430 Kilometern Länge in den Fluten zu versinken

Interview: Ein Quantencode bestimmt unser Leben nach dem Tod

REPORT: Iraq’s secret suppliers

Codierte Nano-Drähte entlarven Biowaffen

Neuromarketing nimmt Kinder ins Visier

Gefahren aus der Zwergenwelt

Auf der Suche nach dem Orgasmus-Hormon

Online-Shops: Samenspender aus dem Internet

Interview mit Prof. Rudi Balling, GBF

Die Jagd auf das 1000-Dollar Genom

Jens Reich im Gespräch mit LifeGen.de

Pflanzenviren auf dem Vormarsch

Chinas unaufhaltsamer Biotech-Aufstieg

Functional Food im Gartenbau:
Obst und Gemüse zwischen Hoffnung und Kommerz


LifeGen.de® ist eine Publikation der
LIFEGEN.DE LTD

Impressum

ONLINE WERBUNG

AGB

(c) 2001-2010 für alle Beiträge bei LifeGen.de®


Dieser Artikel ist kostenlos.

weitere kostenlose Artikel

State aid: France to grant €46.5 million aid for Solar Nano Crystal

The European Commission has decided not to raise objections under EC Treaty state aid rules to the financial support of € 46.5 million that France plans to grant to the Solar Nano Crystal research and development (R&D) programme. The objective of the programme, which is being implemented by a consortium led by PV Alliance LabFab, is to develop the whole value chain of solar energy, from the production of silicon to the module for obtaining solar energy. The Commission found the aid to be compatible with its R&D&I framework (see IP/06/1600) because, in line with EU objectives, it encourages R&D to improve sustainable and diversified sources of energy, that would not have taken place without aid. These benefits outweigh any potential distortions of competition.


France plans to grant a total of €46.5 million to PV Alliance LabFab and other public and private partners in the form of grants and repayable advances. The eligible costs for the purpose of calculating the permissible aid ceiling amount to €129.2 million. The programme was presented in the framework of the French Industrial Innovation Agency (now OSEO) aid scheme, which the Commission approved on 19 July 2006 (see IP/06/1020). Only the €20 million part of the aid to PV Alliance LabFab was subject to an in-depth assessment by the Commission because of its size. The smaller aids either fall under the approved scheme or do not constitute aid because they are granted to public or research organisations.

Solar Nano Crystal aims at improving breakthrough technologies in the solar energy sector, procuring them an environmental and energetic advantage in comparison to fossil fuel energy. It concerns the whole value chain from the production of silicon to the modules that can be installed to obtain solar energy. The project is two-fold: it develops the value chain on two types of silicon, which is the material used to build up cells: metallurgic silicon and polycrystalline silicon. It will be carried out by PV LabFab, a pilot facility set up to carry out the research, test it and validate it, whose shareholders are EDF-ENR, Photowatt and CEA-INES (a non-profit making research organisation).

In particular, the programme aims at boosting the efficiency of the use of metallurgic silicon and polycrystalline silicon.

Following an in-depth examination, the Commission has concluded that the Solar Nano Crystal programme remedies certain market failures, such as the fact thatthe environmental benefits of the research cannot be appropriated by the company and the difficulties to obtain financing due to the high risks of the project. Moreover, the programme will have benefits for the environment, since it aims at reducing CO2 emissions and the EU's energy dependence by 2013. Furthermore, the aid to PV Alliance LabFab has a limited negative impact given its relatively small amount and the fact that it has to be paid back. The impact on competition is limited as the aid beneficiary is a small player and the market is expected to expand.

The non-confidential version of the decision will be made available under the case number N 274/2008 in the State Aid Register on the DG Competition website once any confidentiality issues have been resolved.


(2009-02-26)

Für den Volltext-Zugang zu unseren Inhalten bitte mit Ihrem Usernamen/Passwort hier einloggen, wenn Sie bereits zahlender Abonnent von LifeGen.de sind.

Username:

Passwort:


Passwort vergessen?

Falls Sie kein zahlender Abonnent sind, dann können Sie unseren ClickandBuy Service nutzen.
     
Bestellen Sie unseren KOSTENLOSEN Newsletter mit dem Nachrichten-Überblick

daily news for the life sciences !
anmelden abmelden



LifeGen.de als
RSS Feed
an dieser Stelle

Translated by Google

LifeGen.de in English

LifeGen.de in Russian






Bookmark Buttons

Bookmark bei: Mr. Wong Bookmark bei: Webnews Bookmark bei: BoniTrust Bookmark bei: Oneview Bookmark bei: Linkarena Bookmark bei: Favoriten Bookmark bei: Seekxl Bookmark bei: Kledy.de Bookmark bei: Readster Bookmark bei: Publishr Bookmark bei: Icio Bookmark bei: Power Oldie Bookmark bei: Bookmarks.cc Bookmark bei: Favit Bookmark bei: Bookmarks.at Bookmark bei: Newsider Bookmark bei: Linksilo Bookmark bei: Folkd Bookmark bei: Yigg Bookmark bei: Del.icio.us Bookmark bei: Facebook Bookmark bei: Reddit Bookmark bei: Simpy Bookmark bei: Yahoo Bookmark bei: Google Bookmark bei: Blinklist Bookmark bei: Technorati Information



follow lifegen at http://twitter.com



About LifeGen.de
Our reports predicted major events: the new pandemic, social riots, a rising bioterrorist threat and Barack Obama as President. We move markets by delivering hard facts. The special interest online-magazine LifeGen.de reaches more than 270.000 unique users every year coming from 146 countries worldwide (Data provided by Google Analytics (TM)). The magazine is read by the scientific community, by members of political institutions and by major public media. LifeGen.de was founded in 2001 an is considered to be one of Europes most important lifescience Online-Magazines. More than 8000 articles can be found at the German Business Information (GENIOS). So get involved - and become our lead investor for expanding LifeGen.de to a global player.



Unsere Suchmaschine unterscheidet zwischen Groß- und Kleinschreibung. Um die gefundenen Artikel kostenlos lesen zu können, benötigen Sie ein Abonnement . Alternativ können Sie auch den Service von ClickandBuy nutzen und die Texte einzeln bzw. im Rahmen des Jahres-Tickets erwerben. Die kostenlose Volltextsuche können Sie auch über GENIOS German Business Information starten.


Deutscher Ethikrat
GOOGLE Web Directory Biochemie
MPI Molekulare Genetik Library
Datenbank-Infosystem
(DBIS)

Universitätsklinikum
Heidelberg

Universitätsklinikum Gießen
Universitätsbibliothek Bochum
Deutsche Zentralbibliothek für Medizin (ZB MED)
Deutsches Institut für
Medizinische Dokumentation
und Information
DIMDI

GENIOS - German Business Information
Trust for America's Health
(TFAH)

Net News Global
Transparency International
Deutschland e.V.

Artikel bei
SPIEGEL ONLINE

Arzneimittel - Wenn Kinder keinen Gewinn versprechen

Kollaps des Rentensystems

PARTNER

Zugang zur
MediaClinic



cover